ChromaDex Corporation(CDXC) News

Date	Title
Sep 3	Insider Stock Buying Reaches US$1.3m On ChromaDex
Jul 18	Findings from Published Abstracts Showcase the Importance of Nicotinamide Adenine Dinucleotide (NAD+) in Glaucoma Patients and that Supplementation with Nicotinamide Riboside (NR) Demonstrate Promising Effects